CEU 2019 Session Recordings

Keep your endocrine practice up-to-date with Clinical Endocrinology Update (CEU) Session Recordings. This activity provides the latest information available in clinical endocrinology. Taught by expert faculty in a dynamic meeting format, you will finish viewing the CEU Session Recordings confident that your endocrine practice benefits from the most current and advanced information possible.  Purchase access to the CEU 2019 Session Recordings today!


To purchase access to the CEU 2019 Session Recordings activity, visit the Endocrine Society Online Store by clicking the button below.

Go to Endocrine Society Store

 

Access the latest clinical endocrine updates

Earn AMA PRA Category 1 Credits

Download mp3 audio files to listen on the go

Learning Objectives

Upon completion of this educational activity, learners will be better able to:

  • Discuss state-of-the-art research in endocrinology
  • Demonstrate updated knowledge of the pathophysiology, diagnosis, and treatment of diabetes, obesity, cardiovascular disease, dyslipidemia, as well as adrenal, metabolic, bone, pediatric, pituitary, thyroid, and reproductive endocrine disorders
  • Employ enhanced skills and practice management techniques to improve patient care

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Professionalism
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
Systems-based Practice
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
Endocrine Disruptors
Quality Improvement and Healthcare Delivery
General Endocrinology
Hormone Abuse
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Nutrition
Obesity
Pediatric Endocrinology
Surgery
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Activity summary
Course opens: 
09/25/2019
Course expires: 
12/31/2021
Cost:
$190.00
Rating: 
0
CategorySession TitleFeatured SpeakerSession Duration
AdrenalAdrenal Cushing Diagnosis and Management  Lynette K. Nieman MD0:45
AdrenalAdrenal Incidentaloma: Challenging CasesWilliam F. Young Jr. MD0:45
AdrenalChallenges of Managing Paraganglioma and PheochromocytomaAnand Vaidya MD MMSC0:30
AdrenalAdrenal Questions and AnswersLynette K. Nieman MD0:30
AdrenalDiagnosis and Management of Adrenal InsufficiencyWilliam F. Young Jr. MD0:30
AdrenalQ&A/Panel DiscussionAnand Vaidya MD MMSC, Lynette K. Nieman MD, William F. Young Jr. MD  0:20
 
Calcium and BoneDrug Holidays: What patients and what drugs?E. Michael Lewiecki MD0:30
Calcium and BoneFracture Healing Nelson B. Watts MD0:30
Calcium and BonePremenopausal Osteoporosis Adi Cohen MD0:30
Calcium and BoneFrom T to Z: The Basics of Bone Density Interpretation Micol Rothman MD0:20
Calcium and BoneQ&A/Panel DiscussionE. Michael Lewiecki MD, Nelson B. Watts MD, Adi Cohen MD, Ejigayehu G. Abate MD0:15
Calcium and BoneOverview of Rare Bone DiseaseE. Michael Lewiecki MD0:45
 
DiabetesDiabetes on a Budget  David Matthew Nathan MD0:40
DiabetesContemporary Management of T1D in PregnancyCarol J. Levy MD CDE0:30
DiabetesUpdate on Diabetic NephropathyRobert C. Stanton MD0:30
DiabetesQ&A/Panel Discussion David Matthew Nathan MD, Carol J. Levy MD CDE, Robert C. Stanton MD0:15
DiabetesGlycemic Management after Bariatric SurgeryMary-Elizabeth Patti MD0:30
DiabetesSafety of Novel Agents in T2D ManagementCarol Wysham MD0:30
DiabetesChallenges with Technology: Difficult Pump and CGM CasesAnders L. Carlson MD0:30
DiabetesQ&A/Panel DiscussionMary-Elizabeth Patti MD, Carol Wysham MD, Anders L. Carlson MD0:20
DiabetesTreatment of Diabetes in the ElderlyMark E. Molitch MD0:45
DiabetesRevisiting Old Drugs for T2DDavid Matthew Nathan MD0:45
DiabetesChallenges in the Evaluation and Management of HypoglycemiaMary-Elizabeth Patti MD0:45
 
Female ReproductionHRT for Women Margaret E. Wierman MD0:45
Female ReproductionPCOS TreatmentAnuja Dokras MD PhD0:30
Female ReproductionControversies in the Treatment of Women with Menopausal HormonesAnuja Dokras MD PhD, Cynthia A. Stuenkel MD, Margaret E. Wierman MD0:30
Female ReproductionQ&A/Panel DiscussionAnuja Dokras MD PhD, Cynthia A. Stuenkel MD, Margaret E. Wierman MD0:15
 
Male ReproductionWhen Not to Use Testosterone in Men   Shehzad S. Basaria MD0:45
Male ReproductionHypogonadal CasesFrances J. Hayes MBBCh BAO0:30
Male ReproductionTestosterone Replacement Modalities: Pros, Cons and their Correct UseShehzad S. Basaria MD0:30
Male ReproductionQ&A/Panel DiscussionFrances J. Hayes MBBCh BAO, Shehzad S. Basaria MD0:15
 
Neuroendocrine and PituitaryCushing's Disease: Update on TreatmentMaria Fleseriu MD0:30
Neuroendocrine and PituitaryNon-Functioning Pituitary AdenomasShlomo Melmed MB ChB0:30
Neuroendocrine and PituitaryProlactinomas: Special TopicsMark E. Molitch MD0:30
Neuroendocrine and PituitaryQ&A/Panel DiscussionMaria Fleseriu MD, Shlomo Melmed MB ChB, Mark E. Molitch MD0:15
Neuroendocrine and PituitaryHypophysitis: Etiology and Management Maria Fleseriu MD0:45
Neuroendocrine and PituitaryDiagnosis and Management of HyponatremiaJoseph G. Verbalis MD0:45
 
ObesityHelping Patients Find Motivation for Lifestyle ChangeScott Kahan MD MPH0:30
ObesityWhat’s New in Obesity Treatment?Donna H. Ryan MD0:30
ObesityThe New Cholesterol Management GuidelinesLisa R. Tannock MD0:30
ObesityQ&A/Panel Discussion  Scott Kahan MD MPH, Donna H. Ryan MD, Lisa R. Tannock MD0:15
ObesityPharmacotherapy for Weight ReductionDonna H. Ryan MD0:45
ObesityChallenging Cases in Lipid ManagementLisa R. Tannock MD0:45
 
ThyroidGrave’s OrbitopathyGeorge J. Kahaly MD PhD0:45
ThyroidTreatment Options for Advanced Thyroid CancerStephanie Fish MD0:45
ThyroidMolecular Markers in the Workup of Thyroid NodulesMatthew D. Ringel MD MSc0:45
ThyroidRisk Stratification in Thyroid CancerStephanie Fish MD0:30
ThyroidDiagnosis and Management of Graves’ Hyperthyroidism George J. Kahaly MD PhD0:30
ThyroidQ&A/Panel DiscussionStephanie Fish MD; George J. Kahaly MD PhD0:15
ThyroidClinical Update on Thyroid and PregnancyElizabeth N. Pearce MD MSc0:30
ThyroidUnusual Thyroid Function Tests: Cases to PanelistsStephanie Fish MD, George J. Kahaly MD PhD, Elizabeth N. Pearce MD MSc0:45

Disclosure Policy

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to The Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

PRESENTING FACULTY

The following presenting faculty reported the following relevant financial relationship(s) that they or their spouse/partner have with commercial interests:

Anders Carlson, MD has had his institution receive remuneration for consulting and/or clinical research from Novo Nordisk, Sanofi, Medtronic, Dexcom, Abbott, Eli Lilly, and Insulet. 

Adi Cohen, MD has received research support from Eli Lilly and Amgen. 

Maria Fleseriu, MD has received scientific consulting fees from Novarits and Strongbridge; and has had her institution receive research support from Novartis, Millendo, and Strongbridge

George J. Kahaly, MD, PhD has served as a consultant to Quidel USA; and has had his institution receive a research grant from Quidel. 

E. Micheal Lewiecki, MD has had his employer receive research grants from Radius, Amgen, Mereo, and Bindex; has received income for service on scientific advisory board or consulting from AMgen, Radius, Alexion, Sandoz, Samsung, and Bioepis; has served on speakers bureaus for Radius, Alexion; has worked on project development for University of New Mexico; has received royalties from UpToDate sections; and has served as a board member for the National Osteoporosis Foundation, International Society for Clinical Densitometry, and Osteoporosis Foundation of New Mexico. 

Mark E. Molitch, MD has served as a consultant to Merck, Pfizer, Novartis, Chiasma, Corcept and Janssen; and has worked as a primary investigator for Janssen, Novartis, and Bayer. 

David M. Nathan, MD has received research support from Alere, Inc (now Abbott). 

Mary-Elizabeth Patti, MD has served as a collaborator for NIH R44 grant funded by Xeris Pharmaceuticals; has worked as a consultant for Fractyl and Eiger Pharmaceuticals; and has received investigator-initiated research support to her institution from Xeris Pharmaceuticals and Dexcom.

Micol Rothman, MD has served on the Professional Practice Committee of the American Society for Bone and Mineral Research.

Donna H. Ryan, MD has received consulting fees from Amgen, Bausch Health, Boeringer Ingelheim, Gila Therapeutics, IFA Celtic, Janssen, KVK Tech, Novo Nordisk, Phenomix, Quintiles, Real Appeal (United Health), ReDesign Health, Sanofi, and Scientific Intake; has served on the speakers bureau for Novo Nordisk; has an ownership interest in Gila Therapeutics, Phenomix, Xeno Bioscience, Epitomee, ReDesign Health and Scientific Intake; and has served on the SELECT Steering Committee for Novo Nordisk. 

Joseph G. Verbalis, MD has received consulting fees from Ferring Pharmaceuticals; and has received research support from Corcept Therapeutics. 

Nelson B. Watts, MD has served as a consultant for Abbvie, Amgen, and Sanofi; and served as a speaker for Amgen and Radius. 

Carol Wysham, MD has served as a consultant to Astra Zeneca, Abbott, Janssen, Novo Nordisk, and Sanaofi; has been in the speakers bureau for Astra Zeneca, Boehringer Ingelheim, Janssen, Novo Nordisk, and Sanofi; and has received research funding from Abbott, Novo Nordisk and Mylan. 

The following faculty report no relevant financial relationships: Shehzad S. Basaria, MD; Anuja Dokras, MD, PhD; Stephanie Fish, MD; Scott Kahan, MD, MPH; Carol J. Levy, MD, CDE; Shlomo Melmed, MD; Lynnette K. Nieman, MD;  Elizabeth N. Pearce, MD, MSc; Matthew D. Ringel, MD; Robert C. Stanton, MD; Lisa R. Tannock, MD; Anand Vaidya, MD, MMSc; Margaret E. Wierman, MD; William F. Young, Jr, MD, MSc.

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMERS

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

USE OF PROFESSIONAL JUDGMENT:

The educational content in this self-assessment test relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

DRUGS AND DOSAGES:

When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

The Endocrine Society is proud to partner with industry to advance excellence and promote scientific discovery, medical practice and human health.:

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.The Endocrine Society designates this enduring activity for a maximum of 28.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

Accreditation Period

Course opens: 
09/25/2019
Course expires: 
12/31/2021

Price

Cost:
$190.00

To Begin

Use the links in the table below to go to the CEU Topical Courses to start the activities.  Click the button below the table to visit the Endocrine Society store for purchase options.

Title and Link to CoursePrice
CEU 2019 Session Recordings Library$190.00
CEU 2019: Adrenal Session Recordings$45.00
CEU 2019: Reproductive Health Session Recordings$59.00
CEU 2019: Diabetes Session Recordings$69.00
CEU 2019: Calcium and Bone Session Recordings$49.00
CEU 2019: Obesity/Lipids/Cardiovascular Session Recordings$55.00
CEU 2019: Pituitary Session Recordings$45.00
CEU 2019: Thyroid Session Recordings$59.00

Go to Endocrine Society Store